Evidence map›Paper›PMID 36279452›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2022

Bovine and human endometrium-derived hydrogels support organoid culture from healthy and cancerous tissues.

M Fairuz B Jamaluddin, Arnab Ghosh, Aviraj Ingle, Riazuddin Mohammed, Ayesha Ali, Mohammad Bahrami, Gerard Kaiko, Zamira Gibb, Elysse C Filipe, Thomas R Cox and 9 more

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed, 1 pooled it
13.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 1 synthesis or guideline pooled it, 71 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 1 country.

M Fairuz B JamaluddinGlobal Centre for Gynecological Diseases, The University of Newcastle, Australia, Callaghan, NSW 2308, Australia.ORCID 0000-0002-7343-9298
Arnab GhoshGlobal Centre for Gynecological Diseases, The University of Newcastle, Australia, Callaghan, NSW 2308, Australia.
Aviraj IngleIan Potter NanoBioSensing Facility, NanoBiotechnology Research Laboratory, School of Science, RMIT University, Melbourne, VIC 3000, Australia.
Riazuddin MohammedGlobal Centre for Gynecological Diseases, The University of Newcastle, Australia, Callaghan, NSW 2308, Australia.
Ayesha AliSchool of Biomedical Sciences and Pharmacy, The University of Newcastle, Australia, Callaghan, NSW 2308, Australia.
Mohammad BahramiHunter Medical Research Institute, New Lambton Heights, NSW 2305, Australia.
Gerard KaikoSchool of Biomedical Sciences and Pharmacy, The University of Newcastle, Australia, Callaghan, NSW 2308, Australia.ORCID 0000-0002-3167-3174
Zamira GibbHunter Medical Research Institute, New Lambton Heights, NSW 2305, Australia.ORCID 0000-0002-4864-8880
Elysse C FilipeThe Kinghorn Cancer Centre, Garvan Institute of Medical Research, Medicine and Health, University of New South Wales (UNSW), Sydney, NSW 2052, Australia.
Thomas R CoxThe Kinghorn Cancer Centre, Garvan Institute of Medical Research, Medicine and Health, University of New South Wales (UNSW), Sydney, NSW 2052, Australia.ORCID 0000-0001-9294-1745
Angela BoultonHunter New England Centre for Gynecological Cancer, John Hunter Hospital, Newcastle, NSW 2305, Australia.ORCID 0000-0001-6028-5026
Rachel O'SullivanHunter New England Centre for Gynecological Cancer, John Hunter Hospital, Newcastle, NSW 2305, Australia.
Yvette IusHunter New England Centre for Gynecological Cancer, John Hunter Hospital, Newcastle, NSW 2305, Australia.
Ajay KarakotiGlobal Innovative Centre for Advanced Nanomaterials, College of Engineering, Science, and Environment, The University of Newcastle, Australia, Callaghan, NSW 2308, Australia.
Ajayan VinuGlobal Innovative Centre for Advanced Nanomaterials, College of Engineering, Science, and Environment, The University of Newcastle, Australia, Callaghan, NSW 2308, Australia.
Pravin NaharDepartment of Maternity and Gynecology, John Hunter Hospital, Newcastle, NSW 2305, Australia.
Kenneth JaabackHunter New England Centre for Gynecological Cancer, John Hunter Hospital, Newcastle, NSW 2305, Australia.ORCID 0000-0001-8798-1638
Vipul BansalIan Potter NanoBioSensing Facility, NanoBiotechnology Research Laboratory, School of Science, RMIT University, Melbourne, VIC 3000, Australia.ORCID 0000-0002-3354-4317
Pradeep S TanwarGlobal Centre for Gynecological Diseases, The University of Newcastle, Australia, Callaghan, NSW 2308, Australia.
Hunter Medical Research Institute · AUJohn Hunter Hospital · AUGarvan Institute of Medical Research · AURMIT University · AUUniversity of Newcastle Australia · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Organoid technology has provided unique insights into human organ development, function, and diseases. Patient-derived organoids are increasingly used for drug screening, modeling rare disorders, designing regenerative therapies, and understanding disease pathogenesis. However, the use of Matrigel to grow organoids represents a major challenge in the clinical translation of organoid technology. Matrigel is a poorly defined mixture of extracellular matrix proteins and growth factors extracted from the Engelbreth-Holm-Swarm mouse tumor. The extracellular matrix is a major driver of multiple cellular processes and differs significantly between tissues as well as in healthy and disease states of the same tissue. Therefore, we envisioned that the extracellular matrix derived from a native healthy tissue would be able to support organoid growth akin to organogenesis in vivo. Here, we have developed hydrogels from decellularized human and bovine endometrium. These hydrogels supported the growth of mouse and human endometrial organoids, which was comparable to Matrigel. Organoids grown in endometrial hydrogels were proteomically more similar to the native tissue than those cultured in Matrigel. Proteomic and Raman microspectroscopy analyses showed that the method of decellularization affects the biochemical composition of hydrogels and, subsequently, their ability to support organoid growth. The amount of laminin in hydrogels correlated with the number and shape of organoids. We also demonstrated the utility of endometrial hydrogels in developing solid scaffolds for supporting high-throughput, cell culture-based applications. In summary, endometrial hydrogels overcome a major limitation of organoid technology and greatly expand the applicability of organoids to understand endometrial biology and associated pathologies.

Indexed as

NeoplasmsOrganoidsAnimalsCattleEndometriumFemaleHumansHydrogelsLamininProteomicsHydrogelsLamininECMendometriumhydrogelsorganoiduterus

Identifiers

PMID36279452
PMCPMC9636948
OpenAlexW4307188010

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.